'If you are eating six smaller meals, you've doubled your sugar attacks. So you've got increased risk of tooth decay' - Measuring the effects of GLP-1s on Irish society

"GLP-1 drugs like Ozempic and Wegovy are not merely weight-loss solutions; they serve as indicators of societal attitudes towards obesity and thinness, revealing deeper cultural issues."

"While these medications can drastically improve the lives of individuals struggling with obesity, they also risk restigmatizing the disease and complicating the conversation around body acceptance."

GLP-1 drugs, initially developed for diabetes and obesity, are now popular for weight loss. While they significantly benefit many individuals with obesity, experts express concern about their long-term effects and the potential for increased stigma surrounding the condition. These medications reflect societal attitudes towards body image and thinness, raising questions about their role in promoting health versus reinforcing negative perceptions of body acceptance. The impact of these drugs on culture and behavior is complex and multifaceted.

Read at Independent